Prioritizing Technology of Ai-Driven Enablers for Efficient Distribution of Finished Pharmaceutical Products in Indian Markets: An Ahp Approach
International Journal of Drug Delivery Technology · 21.05.2026 · 16 (29s)
DOI: 10.25258/ijddt.16.29s.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 21.05.2026. Verfasst von Dr. Sunil Saxena.
Abstract (Originalsprache)
Purpose
This paper aims to outline and describe the main AI-based enablers that can serve to optimize the distribution of finished pharmaceutical products in the Indian markets. It is aimed at identifying the technological, operational, and regulatory aspects that play the greatest role in enhancing the performance of distribution using artificial intelligence. Design/Methodology/Approach: Fuzzy Analytic Hierarchy Process (Fuzzy AHP) - Multi-Criteria DecisionMaking (MCDM) method was used to analyze and prioritize the key AI-based enablers that affect pharmaceutical distribution. Data were obtained by interviewing 15 professionals, such as pharmaceutical supply chain managers, logistics professionals, data scientists, and academic scholars in the field of healthcare operations and artificial intelligence. Expert judgments were reviewed based on pair-wise comparison and fuzzy logic principles to give relative weights and determine the rankings of enablers.
Findings
The review has identified Cold Chain Monitoring and Management, Quality Control Automation, and Predictive Demand Forecasting as the strongest enablers that lead to efficiency in the pharmaceutical distribution process. The importance of Counterfeit Detection and Prevention and Real-Time Supply Chain Visibility was moderate as they positively affected the enhancement of transparency and product authenticity. In the meantime, supportive roles were performed by Inventory Optimization, Intelligent Dispatch Planning, and Regulatory Compliance Automation that helped to increase coordination and manage regulatory alignment. The results show that AI-based temperature control, predictive analytics, and quality assurance mechanisms are the main factors supporting efficient distribution.
Implications
The findings would be useful to pharmaceutical companies, transportation partners, and policymakers intending to enhance distribution networks by using artificial intelligence. The paper highlights the need to invest in AI-assisted cold-chain infrastructure, automated quality checking, and services prediction to enhance service reliability. Originality/Value: The study is also one of the first to use Fuzzy AHP to rank AI enablers in the business of Indian pharmaceutical distribution. It ushers in an expert-led, systematic method of decision making that takes a balance between theoretical knowledge and industry. The study qualifies as conceptually and empirically useful in that it seeks to depict important technological priorities that can serve as a guiding tool in undertaking strategic investment and policy efforts to create wise, resilient, and strong pharmaceutical distribution systems in India.
Zitieren
APA
Saxena, D. S. (2026). Prioritizing Technology of Ai-Driven Enablers for Efficient Distribution of Finished Pharmaceutical Products in Indian Markets: An Ahp Approach. International Journal of Drug Delivery Technology, 16(29s). https://doi.org/10.25258/ijddt.16.29s.76
Vancouver
Saxena DS. Prioritizing Technology of Ai-Driven Enablers for Efficient Distribution of Finished Pharmaceutical Products in Indian Markets: An Ahp Approach. International Journal of Drug Delivery Technology. 2026;16(29s). doi:10.25258/ijddt.16.29s.76
BibTeX
@article{Saxena2026,
author = {Saxena, Dr. Sunil},
title = {Prioritizing Technology of Ai-Driven Enablers for Efficient Distribution of Finished Pharmaceutical Products in Indian Markets: An Ahp Approach},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {29s},
doi = {10.25258/ijddt.16.29s.76}
}
EUVIMED